Drug Development, Not Conflicts, Dominates Gottlieb's Confirmation Hearing
Executive Summary
The most questions were asked about issues such as accelerated approval and clinical trials, not Gottlieb's ties to industry.
You may also be interested in...
Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly
The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to question nominee's work history extensively during previous confirmation hearings.
Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly
The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to question nominee's work history extensively during previous confirmation hearings.
Drug Development Questions Dominate Hahn's Confirmation, Despite Talk About E-Cigs
A plurality of the questions from the Senate HELP Committee at Stephen Hahn's confirmation hearing to head the US FDA focused on drug development issues, despite the time lawmakers spent discussing the agency's regulation of e-cigarettes.